Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

ICAD

Icad Inc

Apr 26 • 04:00PM ET

1.47

Dollar change -0.01
Percentage change -0.68	%

Healthcare • Medical Devices • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF IWC

Index	-	P/E	-	EPS (ttm)	-0.22	Insider Own	5.88%	Shs Outstand	26.35M	Perf Week	-4.55%
Market Cap	39.01M	Forward P/E	-	EPS next Y	-0.19	Insider Trans	0.00%	Shs Float	24.98M	Perf Month	-8.13%
Income	-5.54M	PEG	-	EPS next Q	-0.06	Inst Own	26.03%	Short Float	1.73%	Perf Quarter	-1.34%
Sales	20.46M	P/S	1.91	EPS this Y	13.81%	Inst Trans	-4.82%	Short Ratio	2.09	Perf Half Y	5.00%
Book/sh	1.27	P/B	1.16	EPS next Y	19.66%	ROA	-15.26%	Short Interest	0.43M	Perf Year	7.30%
Cash/sh	0.82	P/C	1.80	EPS next 5Y	15.00%	ROE	-20.81%	52W Range	1.05 - 3.97	Perf YTD	-16.95%
Dividend Est.	-	P/FCF	-	EPS past 5Y	11.68%	ROI	-16.44%	52W High	-62.97%	Beta	1.35
Dividend TTM	-	Quick Ratio	4.26	Sales past 5Y	-4.67%	Gross Margin	78.62%	52W Low	40.00%	ATR (14)	0.14
Dividend Ex-Date	-	Current Ratio	4.40	EPS Y/Y TTM	59.25%	Oper. Margin	-38.05%	RSI (14)	41.21	Volatility	7.91% 9.50%
Employees	69	Debt/Eq	0.01	Sales Y/Y TTM	-26.79%	Profit Margin	-27.08%	Recom	1.00	Target Price	4.83
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	142.20%	Payout	-	Rel Volume	0.67	Prev Close	1.48
Sales Surprise	10.73%	EPS Surprise	63.64%	Sales Q/Q	-26.94%	Earnings	Mar 12 AMC	Avg Volume	207.10K	Price	1.47
SMA20	-9.37%	SMA50	-10.20%	SMA200	-19.53%	Trades		Volume	138,193	Change	-0.68%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-18-22	Downgrade	Guggenheim	Buy → Neutral
Apr-22-21	Initiated	Guggenheim	Buy	$24
Mar-23-21	Initiated	BTIG Research	Buy	$25
Feb-26-21	Initiated	Oppenheimer	Outperform	$27
Jan-29-21	Initiated	Cantor Fitzgerald	Overweight	$19
Dec-03-20	Initiated	B. Riley Securities	Buy	$15
Feb-05-20	Initiated	JMP Securities	Mkt Outperform	$15
Jan-09-20	Initiated	Lake Street	Buy	$14
Dec-09-08	Reiterated	Canaccord Adams	Buy	$5 → $3.50
Aug-01-08	Reiterated	MDB Capital Group	Buy	$5.50 → $6
May-14-08	Reiterated	Canaccord Adams	Buy	$4 → $4.50
Feb-14-08	Initiated	Sun Trust Rbsn Humphrey	Buy	$4
Jan-24-07	Reiterated	Dawson James	Speculative Buy	$4 → $5

Show Previous Ratings

Apr-11-24 08:00AM	iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium (GlobeNewswire)
Apr-09-24 08:00AM	iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation (GlobeNewswire) +10.43%
Apr-08-24 04:29PM	iCAD's ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting (GlobeNewswire)
Apr-03-24 08:00AM	iCAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs) (GlobeNewswire) +18.75%
Apr-02-24 08:00AM	iCAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale (GlobeNewswire) +5.26%
09:00AM	Loading…
Mar-19-24 09:00AM	iCAD Releases Enhanced ProFound Detection Workstation Features to Streamline Mammogram Interpretation for Radiologists (GlobeNewswire)
Mar-14-24 02:00PM	Artificial Intelligence, Real Profits: 3 Stocks to Outsmart the Market (InvestorPlace) -10.56%
Mar-13-24 08:46AM	iCAD, Inc. (NASDAQ:ICAD) Q4 2023 Earnings Call Transcript (Insider Monkey)
07:01AM	Q4 2023 ICAD Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-12-24 04:22PM	Icad: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results (GlobeNewswire)
Mar-01-24 07:30AM	The Hot List: 3 AI Stocks Worth Buying on Weakness (InvestorPlace)
Feb-28-24 08:05AM	iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings (GlobeNewswire) +12.10%
Feb-27-24 09:05AM	iCAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.c ) (GlobeNewswire)
08:05AM	iCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 (GlobeNewswire)
08:00AM	Loading…
Feb-06-24 08:00AM	iCAD to Participate in the BTIG at Snowbird: 11th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire)
Jan-30-24 08:00AM	iCAD Expands Board of Directors with Appointment of Michael J. Doyle, FACHE as New Board Member (GlobeNewswire)
Dec-18-23 08:00AM	iCAD Expands Executive Sales Leadership Team as Business Grows (GlobeNewswire)
Dec-05-23 06:00AM	Wealth Accumulation: 3 Stocks with Multibagger Potential (InvestorPlace)
Nov-28-23 08:00AM	iCAD's AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE Healthcare (GlobeNewswire) +14.60%
Nov-27-23 08:00AM	iCAD's ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease (GlobeNewswire)
Nov-22-23 08:12AM	Discover Future Growth Stocks: 3 Penny Stocks Poised for Massive Returns (InvestorPlace)
Nov-20-23 08:00AM	iCAD and CancerIQ Announce Partnership to Integrate AI-Enabled Technology With Best-in-Class Risk Assessment and Care Management Platform Offering A Comprehensive Breast Health Care Solution (GlobeNewswire)
Nov-14-23 10:56AM	iCAD, Inc. (NASDAQ:ICAD) Q3 2023 Earnings Call Transcript (Insider Monkey) -6.99%
08:00AM	iCAD to Participate in the 14th Annual Craig-Hallum Alpha Select Conference (GlobeNewswire)
Nov-13-23 04:06PM	Icad: Q3 Earnings Snapshot (Associated Press Finance) +6.72%
04:01PM	iCAD Reports Financial Results for Third Quarter Ended September 30, 2023 (GlobeNewswire)
Oct-30-23 08:00AM	iCAD to Report Third Quarter 2023 Financial Results on November 13, 2023 (GlobeNewswire)
Oct-24-23 04:03PM	The 7 Most Undervalued AI Penny Stocks to Buy: October 2023 (InvestorPlace)
Oct-23-23 08:01AM	iCAD, Inc. Announces Sale of Xoft, its Brachytherapy Business Line, to Elekta (GlobeNewswire) -5.00%
07:19PM	Loading…
Oct-08-23 07:19PM	7 Trailblazing AI Stocks to Buy on Any Weakness (InvestorPlace)
Sep-01-23 05:07AM	3 Up-and-Coming Stocks to Put on Your Must-Buy List (InvestorPlace)
Aug-27-23 11:53AM	10 Best AI Penny Stocks to Buy Now (Insider Monkey)
Aug-16-23 08:00AM	Health Canada Grants Device License for iCAD's ProFound Risk 2.0, Revolutionizing Breast Cancer Risk Via a 1-2 Year Assessment (GlobeNewswire)
Aug-15-23 07:58AM	Q2 2023 ICAD Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-14-23 05:48PM	Icad: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	iCAD Reports Financial Results for Second Quarter Ended June 30, 2023 (GlobeNewswire)
08:00AM	iCAD and Google Health Expand Integration of Googles AI Technology with iCADs ProFound Breast Health Suite for 2D Mammography for Use as Independent Reader (GlobeNewswire)
Aug-07-23 11:49AM	5 AI Stocks That Could Turn $50,000 Into $1 Million (InvestorPlace) -7.78%
Jul-31-23 08:00AM	iCAD to Report Second Quarter 2023 Financial Results on August 14, 2023 (GlobeNewswire) -5.78%
Jul-25-23 09:34PM	If You Can Only Buy One Tech Stock, It Better Be One of These 7 Names (InvestorPlace)
Jul-23-23 09:49AM	Investors in iCAD (NASDAQ:ICAD) from three years ago are still down 63%, even after 80% gain this past week (Simply Wall St.)
Jul-18-23 08:00AM	iCAD Signs Strategic Commercial Agreement with Radiology Partners, the Nations Largest Radiology Practice (GlobeNewswire) +74.27%
Jul-12-23 08:00AM	iCADs ProFound Insights, ProFound Impact Webinar Series to Feature Cleveland Clinic (GlobeNewswire)
Jul-10-23 08:00AM	iCAD Offers ROI Analysis Based on Real-World Results from its ProFound Breast AI Suite at AHRA Annual Meeting (GlobeNewswire) +17.77%
Jul-07-23 02:30PM	7 Stocks to Target for Triple-Digit Returns in 2023 (InvestorPlace) +7.07%
Jun-25-23 02:17PM	CEO Shuffle: 7 Stocks That Could Gain Momentum From New Leadership (InvestorPlace)
Jun-08-23 06:31AM	There Is A Reason iCAD, Inc.'s (NASDAQ:ICAD) Price Is Undemanding (Simply Wall St.)
May-18-23 04:40PM	3 High-Reward Stocks Riding the AI Boom (InvestorPlace)
08:00AM	iCADs ProFound AI Breast Suite Wins U.S. General Services Administrations AI Healthcare Challenge Award (GlobeNewswire)
May-16-23 11:13AM	Q1 2023 ICAD Inc Earnings Call (Thomson Reuters StreetEvents) -8.80%
May-15-23 05:25PM	Icad (ICAD) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:22PM	Icad: Q1 Earnings Snapshot (AP Finance)
04:01PM	iCAD Reports Financial Results for First Quarter Ended March 31, 2023 (GlobeNewswire)
May-11-23 08:00AM	New Long-Term Real-World Research Confirms Xoft Skin eBx is as Safe and Effective as Mohs Surgery (GlobeNewswire) -5.07%
May-03-23 08:00AM	iCAD Showcases Breast AI Suite at Society of Breast Imaging Symposium, Worlds Largest Breast Imaging Conference (GlobeNewswire)
May-01-23 08:00AM	iCAD to Report First Quarter 2023 Financial Results on May 15, 2023 (GlobeNewswire)
Apr-25-23 08:00AM	iCADs ProFound Insights, ProFound Impact Webinar Series to Feature Boca Raton Regional Hospital (GlobeNewswire)
Apr-20-23 08:00AM	New and Real-World Clinical Evidence Confirms ProFound AI Increases Cancer Detection without Increasing the Rate of Recalls and Reveals Critical Clues to Inform Clinical Decisions (GlobeNewswire)
Apr-17-23 08:00AM	iCAD Strengthens Leadership Team with Appointment of Chief Financial Officer and New Senior Executives (GlobeNewswire)
Apr-07-23 04:28PM	The 3 Best Millionaire-Maker Stocks to Buy for April 2023 (InvestorPlace)
Apr-06-23 06:08AM	Trade Alert: The Executive Chair Of iCAD, Inc. (NASDAQ:ICAD), Dana Brown, Has Just Spent US$52k Buying A Few More Shares (Simply Wall St.)
Apr-05-23 06:11AM	Daily Vickers Top Buyers & Sellers for 04/05/2023 (Argus Research) +11.30%
Apr-04-23 08:00AM	ProFound AI Risk Outperforms Traditional, Widely-Accepted Breast Cancer Risk Models for Both Short-term and Long-term Risk Assessments (GlobeNewswire)
Mar-30-23 08:26AM	iCAD, Inc. (NASDAQ:ICAD) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-28-23 05:15PM	Icad (ICAD) Reports Q4 Loss, Misses Revenue Estimates (Zacks) -6.98%
04:01PM	iCAD Reports Financial Results for Fourth Quarter ended December 31, 2022 and Year End (GlobeNewswire)
07:47AM	We Think iCAD (NASDAQ:ICAD) Needs To Drive Business Growth Carefully (Simply Wall St.)
Mar-23-23 08:00AM	iCADs Breast AI Suite Empowers Customers to Lead the Way in Support of FDAs National Breast Density Reporting Standard (GlobeNewswire)
Mar-14-23 03:42PM	7 Tantalizing Technology Stocks to Buy for Long-Term Growth (InvestorPlace) -7.14%
Mar-13-23 08:30AM	iCAD Previews Fourth Quarter Financial Results, Full Report on March 28, 2023 (GlobeNewswire) -35.56%
08:00AM	iCAD Announces Leadership Transition (GlobeNewswire)
Mar-01-23 08:00AM	New Real-World Clinical Evidence Confirms ProFound AI Boosts Radiologists Efficiency and Accuracy (GlobeNewswire) +7.17%
Feb-23-23 10:14AM	7 Super Speculative Stocks That Could Make You Very Rich (InvestorPlace)
Feb-12-23 09:12AM	iCAD (NASDAQ:ICAD investor three-year losses grow to 83% as the stock sheds US$8.1m this past week (Simply Wall St.)
Feb-09-23 08:00AM	iCAD to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference (GlobeNewswire) -6.28%
Jan-23-23 08:00AM	iCAD Announces CFO Transition and Hires New Senior Vice President, US Commercial Sales, AI (GlobeNewswire)
Jan-11-23 08:00AM	iCAD Announces Board of Directors Transition (GlobeNewswire)
Dec-30-22 07:11AM	iCAD, Inc. (NASDAQ:ICAD) Is Expected To Breakeven In The Near Future (Simply Wall St.) +8.28%
Dec-22-22 06:00AM	7 Drug Stocks That Will Soar in 2023 (InvestorPlace)
Dec-09-22 09:00AM	Our 7 Top Nasdaq Stock Picks for 2023 (InvestorPlace)
Dec-08-22 08:00AM	iCAD features Solis Mammography in upcoming ProFound Insights, ProFound Impact webinar (GlobeNewswire)
Nov-28-22 08:00AM	iCAD and Google Health Ink Strategic Development and Commercialization Agreement (GlobeNewswire) +5.56%
Nov-21-22 08:00AM	Positive New Research Presented at RSNA 2022 Reaffirms iCADs Breast AI Suite Improves Radiologists Performance and Breast Cancer Detection (GlobeNewswire)
Nov-19-22 07:07AM	iCAD Third Quarter 2022 Earnings: Misses Expectations (Simply Wall St.)
Nov-17-22 08:02AM	iCAD, Inc. (NASDAQ:ICAD) insiders are still down US$164k after purchasing last year, recent gain helped regain some losses (Simply Wall St.)
Nov-15-22 04:13PM	iCAD to Participate in the 13th Annual Craig-Hallum Alpha Select Conference (GlobeNewswire) +7.04%
Nov-14-22 08:00AM	iCAD to Present at HLTH 2022 With Google (GlobeNewswire)
Nov-10-22 05:45PM	Icad (ICAD) Reports Q3 Loss, Lags Revenue Estimates (Zacks) +14.46%
04:03PM	iCAD Reports Financial Results for Third Quarter Ended September 30, 2022 (GlobeNewswire)
04:01PM	iCAD to Join Forces with Radiology Partners, the Nations Largest Radiology Practice (GlobeNewswire)
Oct-27-22 08:40AM	iCAD to Report Third Quarter 2022 Financial Results on November 10, 2022 (GlobeNewswire)
Oct-19-22 07:02AM	Is iCAD (NASDAQ:ICAD) In A Good Position To Invest In Growth? (Simply Wall St.)
Oct-14-22 11:34AM	7 Little-Known Stocks With Millionaire-Maker Potential (InvestorPlace)
Oct-11-22 08:00AM	iCAD and Solis Mammography Ink Deal to Collaborate on Use of AI to Evaluate Risk of Cardiovascular Disease (GlobeNewswire)
Sep-07-22 08:00AM	iCAD To Participate in The Lake Street Capital Markets 6th Annual Best Ideas Growth (BIG6) Conference on September 14, 2022 (GlobeNewswire)
Sep-05-22 07:34AM	iCAD (NASDAQ:ICAD) shareholders have endured a 76% loss from investing in the stock a year ago (Simply Wall St.)
Aug-29-22 08:00AM	iCAD Customers in the U.S. and Europe Increasingly Adopting Companys Full Suite of Breast AI Technologies via Subscription Model (GlobeNewswire)
Aug-19-22 09:35AM	After Plunging 29.6% in 4 Weeks, Here's Why the Trend Might Reverse for Icad (ICAD) (Zacks) -6.67%
Aug-11-22 07:00AM	iCAD (ICAD) Q2 2022 Earnings Call Transcript (Motley Fool) -12.04%

iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment includes image analysis and workflow products. The Cancer Therapy segment relates to radiation therapy products. The company was founded in 1984 and is headquartered in Nashua, NH.

Open in Screener

ARCT

Arcturus Therapeutics Holdings Inc

Apr 26 • 04:00PM ET

26.55

Dollar change +0.38
Percentage change 1.45	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

ARCT Arcturus Therapeutics Holdings Inc daily Stock Chart

Held by: ARKG VTI IWM VXF IWN IBB DFAT AVUV LABU SCHA

Index	RUT	P/E	-	EPS (ttm)	-1.04	Insider Own	8.75%	Shs Outstand	26.83M	Perf Week	2.19%
Market Cap	714.73M	Forward P/E	-	EPS next Y	-0.18	Insider Trans	-1.30%	Shs Float	24.56M	Perf Month	-19.20%
Income	-26.59M	PEG	-	EPS next Q	0.10	Inst Own	93.40%	Short Float	18.78%	Perf Quarter	-16.30%
Sales	160.88M	P/S	4.44	EPS this Y	-162.18%	Inst Trans	-0.13%	Short Ratio	9.52	Perf Half Y	40.25%
Book/sh	10.38	P/B	2.56	EPS next Y	93.03%	ROA	-6.04%	Short Interest	4.61M	Perf Year	-0.38%
Cash/sh	12.89	P/C	2.06	EPS next 5Y	-	ROE	-9.69%	52W Range	17.52 - 43.81	Perf YTD	-15.79%
Dividend Est.	-	P/FCF	-	EPS past 5Y	12.40%	ROI	-8.73%	52W High	-39.40%	Beta	2.65
Dividend TTM	-	Quick Ratio	4.72	Sales past 5Y	310.16%	Gross Margin	-	52W Low	51.54%	ATR (14)	1.85
Dividend Ex-Date	-	Current Ratio	4.72	EPS Y/Y TTM	-395.33%	Oper. Margin	-4.30%	RSI (14)	36.13	Volatility	5.91% 6.25%
Employees	180	Debt/Eq	0.11	Sales Y/Y TTM	-21.90%	Profit Margin	-16.53%	Recom	1.30	Target Price	67.62
Option/Short	Yes / Yes	LT Debt/Eq	0.09	EPS Q/Q	-107.43%	Payout	-	Rel Volume	0.56	Prev Close	26.17
Sales Surprise	-10.23%	EPS Surprise	67.75%	Sales Q/Q	-82.40%	Earnings	May 08 AMC	Avg Volume	484.59K	Price	26.55
SMA20	-11.40%	SMA50	-22.04%	SMA200	-11.32%	Trades		Volume	272,697	Change	1.45%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-13-23	Initiated	Canaccord Genuity	Buy	$90
Jul-24-23	Initiated	William Blair	Outperform	$71
May-11-23	Upgrade	H.C. Wainwright	Neutral → Buy	$19 → $51
Nov-14-22	Resumed	Wells Fargo	Overweight	$35
Nov-10-22	Downgrade	Robert W. Baird	Neutral → Underperform	$18
Nov-03-22	Upgrade	Citigroup	Neutral → Buy	$22 → $35
Nov-02-22	Upgrade	Barclays	Underweight → Equal Weight	$16 → $25
Aug-10-22	Downgrade	Raymond James	Mkt Perform → Underperform
Jul-19-22	Resumed	Cantor Fitzgerald	Overweight	$86 → $39
May-11-22	Upgrade	Robert W. Baird	Underperform → Neutral	$21 → $18
Apr-21-22	Downgrade	Citigroup	Buy → Neutral	$86 → $29
Jan-31-22	Upgrade	Raymond James	Underperform → Mkt Perform
Aug-12-21	Downgrade	Raymond James	Mkt Perform → Underperform
Aug-11-21	Downgrade	Goldman	Neutral → Sell	$29
Aug-10-21	Downgrade	Robert W. Baird	Neutral → Underperform	$31
Jul-02-21	Initiated	Cantor Fitzgerald	Overweight	$71
Jun-25-21	Resumed	Goldman	Neutral	$29
Jun-21-21	Downgrade	Barclays	Equal Weight → Underweight	$33 → $25
Jun-04-21	Resumed	Robert W. Baird	Neutral	$31
Feb-17-21	Downgrade	B. Riley Securities	Neutral → Sell

Show Previous Ratings

Apr-25-24 04:01PM	Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024 (Business Wire)
Mar-28-24 01:34AM	Arcturus Therapeutics Holdings Inc (ARCT) Insider Sells Shares (GuruFocus.com)
Mar-22-24 01:26AM	Arcturus Therapeutics Holdings Inc's Chief Scientific Officer & COO Pad Chivukula Sells ... (GuruFocus.com)
Mar-09-24 01:09PM	12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds (Insider Monkey)
Mar-08-24 12:10PM	Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2023 Earnings Call Transcript (Insider Monkey)
06:54AM	Loading…
06:54AM	Q4 2023 Arcturus Therapeutics Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-07-24 10:42PM	Arcturus Therapeutics Reports Fiscal Year 2023 Financial Results and Pipeline Developments (GuruFocus.com)
05:10PM	Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:21PM	Arcturus Therapeutics: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progress (Business Wire)
Mar-04-24 01:23PM	Arcturus (ARCT) Stock Surges 73% in 3 Months: Here's Why (Zacks) -5.24%
Feb-26-24 03:20PM	7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff (InvestorPlace) +9.41%
09:00AM	Arcturus Therapeutics to Present at the Barclays 26th Annual Global Healthcare Conference (Business Wire)
Feb-22-24 08:30AM	Arcturus Therapeutics Receives Orphan Medicinal Product Designation from the European Commission (EC), for ARCT-032, for the Treatment of Cystic Fibrosis (Business Wire) +6.12%
Feb-21-24 01:04PM	Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for February 2024 (InvestorPlace)
04:39PM	Loading…
Feb-20-24 04:39PM	3 Tech Stocks That Could Be Multibaggers in the Making: February Edition (InvestorPlace)
09:00AM	Arcturus Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 7, 2024 (Business Wire)
Feb-05-24 08:30AM	New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrate Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster (PR Newswire)
Jan-23-24 04:16AM	18 High Growth Low PE Stocks (Insider Monkey)
Jan-05-24 01:17PM	PassPort Technologies Commences Collaborative Research with Arcturus Therapeutics to Evaluate Transdermal mRNA delivery systems (PR Newswire)
Dec-21-23 08:00AM	CSL and Arcturus Therapeutics ARCT-154 Demonstrates Non-Inferiority to Original Strain and Superior Immunogenicity to Omicron BA.4/5 Variant Compared to First-Generation mRNA Vaccine Booster (Business Wire)
Dec-17-23 12:03PM	7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar (InvestorPlace)
Dec-13-23 10:39PM	3 Biotech Stocks With Promising Pipelines and Big Growth Potential in 2024 (InvestorPlace) +11.18%
Dec-08-23 10:13AM	12 Best Healthcare Stocks For the Long-Term (Insider Monkey)
Dec-04-23 08:30AM	Arcturus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Nov-28-23 08:05AM	Japan's Ministry of Health, Labour and Welfare Approves CSL and Arcturus Therapeutics' ARCT-154, the first Self-Amplifying mRNA vaccine approved for COVID in adults (PR Newswire)
07:56AM	Arcturus' (ARCT) CF Drug Gets FDA's Orphan Status, Stock Up (Zacks)
Nov-27-23 08:30AM	Arcturus Therapeutics Receives Orphan Drug Designation from the U.S. FDA for ARCT-032, for the Treatment of Cystic Fibrosis (Business Wire) +7.90%
Nov-15-23 01:26PM	Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q3 2023 Earnings Call Transcript (Insider Monkey) +16.08%
11:30AM	Q3 2023 Arcturus Therapeutics Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
05:19PM	Loading…
Nov-14-23 05:19PM	Arcturus Therapeutics Holdings Inc (ARCT) Reports Significant Revenue Growth in Q3 2023 (GuruFocus.com) +9.54%
04:13PM	Arcturus Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Arcturus Therapeutics Announces Third Quarter 2023 Financial Update and Pipeline Progress (Business Wire)
10:56AM	The 3 Most Undervalued Biotech Stocks to Buy: November 2023 (InvestorPlace)
Oct-25-23 04:01PM	Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 14, 2023 (Business Wire)
Oct-23-23 04:01PM	Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences (Business Wire)
Oct-04-23 11:01PM	Insider Sell: Pad Chivukula Sells 5,000 Shares of Arcturus Therapeutics Holdings Inc (GuruFocus.com)
08:30AM	Arcturus Therapeutics Joint Venture mRNA Manufacturing Partner, ARCALIS, Awarded Additional Financial Grants from Japanese Government (Business Wire)
Sep-26-23 08:30AM	Arcturus Therapeutics and Cystic Fibrosis Foundation Extend Agreement to Advance ARCT-032, an Investigational Messenger RNA (mRNA) Therapeutic to Treat Cystic Fibrosis (Business Wire)
Sep-19-23 08:30AM	Study Shows Novel sa-mRNA Vaccines Offer Robust, Broad, Enduring Protection Against COVID-19 Variants (Business Wire)
Sep-05-23 08:30AM	Arcturus Therapeutics and CSL Announce European Medicines Agency Validates Marketing Authorization Application for ARCT-154 Vaccine to Prevent COVID-19 (Business Wire)
Aug-17-23 08:30AM	Arcturus Therapeutics to Attend Upcoming Investor Conferences (Business Wire)
Aug-14-23 09:00AM	Arcturus Therapeutics Joint Venture mRNA Manufacturing Partner, ARCALIS, Awarded $115 Million in Grants from the Japanese Government (Business Wire) +6.37%
Aug-10-23 07:15AM	New Strong Sell Stocks for August 10th (Zacks)
Aug-08-23 02:39PM	Why Shares of Arcturus Therapeutics Dropped on Tuesday (Motley Fool) -19.22%
01:09PM	Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q2 2023 Earnings Call Transcript (Insider Monkey)
08:43AM	Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Analysts Just Cut Their EPS Forecasts Substantially (Simply Wall St.)
07:39AM	Q2 2023 Arcturus Therapeutics Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-23 07:50PM	Arcturus Therapeutics (ARCT) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
06:43PM	Arcturus Therapeutics: Q2 Earnings Snapshot (AP Finance)
04:01PM	Arcturus Therapeutics Announces Second Quarter 2023 Financial Update and Pipeline Progress (Business Wire)
Aug-04-23 09:21AM	4 Biotech Stocks Set to Outpace Q2 Earnings Estimates (Zacks)
Jul-28-23 05:14PM	3 Biotech Stocks to Buy Before the Breakout (InvestorPlace)
Jul-24-23 04:01PM	Arcturus Therapeutics to Report Second Quarter 2023 Financial Results and Provide Corporate Update on August 7, 2023 (Business Wire) +5.38%
Jul-18-23 06:22AM	3 Biotech Stocks for Getting Rich in 2023 (InvestorPlace)
Jul-16-23 08:18PM	Arcturus Therapeutics (ARCT) Surges 15.0%: Is This an Indication of Further Gains? (Zacks)
Jul-14-23 02:36PM	Biotech, Cboe Rally To New Highs, Top Buy Points (Investor's Business Daily) +15.03%
Jul-05-23 06:15AM	Calculating The Intrinsic Value Of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) (Simply Wall St.)
Jun-14-23 08:24AM	Arcturus Therapeutics Holdings (NASDAQ:ARCT) shareholder returns have been stellar, earning 225% in 5 years (Simply Wall St.)
Jun-01-23 08:30AM	Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for ARCT-810, mRNA Therapeutic Candidate for Ornithine Transcarbamylase Deficiency (Business Wire)
May-18-23 07:16AM	Growth Investors: Industry Analysts Just Upgraded Their Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Revenue Forecasts By 76% (Simply Wall St.)
May-12-23 02:04AM	4 big analyst picks: Albemarle scores fresh Overweight rating (Investing.com) -5.50%
May-09-23 05:35PM	Arcturus Therapeutics (ARCT) Q1 Earnings and Revenues Miss Estimates (Zacks)
04:37PM	Arcturus Therapeutics: Q1 Earnings Snapshot (AP Finance)
04:01PM	Arcturus Therapeutics Announces First Quarter 2023 Financial Update and Pipeline Progress (Business Wire)
09:29AM	12 Best Fast Growth Stocks to Buy Now (Insider Monkey)
May-08-23 07:43AM	Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock? (Simply Wall St.) +5.24%
Apr-28-23 01:39PM	12 Best Fast Growth Stocks to Buy Now (Insider Monkey)
Apr-26-23 08:30AM	Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 9, 2023 (Business Wire) -5.09%
Apr-17-23 07:10AM	Why Investors Shouldn't Be Surprised By Arcturus Therapeutics Holdings Inc.'s (NASDAQ:ARCT) 79% Share Price Surge (Simply Wall St.)
Mar-30-23 08:29AM	Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-29-23 11:45AM	Why Arcturus Therapeutics Stock Is Soaring Today (Motley Fool) +30.13%
Mar-28-23 05:15PM	Arcturus Therapeutics (ARCT) Beats Q4 Earnings and Revenue Estimates (Zacks)
04:01PM	Arcturus Therapeutics Announces Fourth Quarter 2022 Financial Update and Pipeline Progress (Business Wire)
Mar-27-23 09:11AM	Market Sentiment Around Loss-Making Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) (Simply Wall St.)
Mar-23-23 06:18AM	Immuneering Corporation (IMRX) Soars 16.9%: Is Further Upside Left in the Stock? (Zacks)
Mar-07-23 08:00AM	Arcturus Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on March 28, 2023 (Business Wire)
Feb-06-23 08:30AM	Arcturus Therapeutics to Attend Upcoming Investor Conferences (Business Wire)
Jan-31-23 08:30AM	Arcturus Therapeutics Announces Clinical Trial Application for ARCT-032 Received Approval to Proceed into First-in-Human Studies to Treat Cystic Fibrosis (Business Wire)
Dec-28-22 11:35AM	Swelling losses haven't held back gains for Arcturus Therapeutics Holdings (NASDAQ:ARCT) shareholders since they're up 109% over 5 years (Simply Wall St.)
Dec-19-22 08:30AM	Arcturus Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference (Business Wire) -7.04%
Dec-13-22 08:30AM	Arcturus Appoints John Markels, Ph.D. to its Board of Directors (Business Wire) +7.29%
Dec-12-22 08:30AM	CSL Announces Closing of Global Collaboration and Licensing Agreement with Arcturus Therapeutics (PR Newswire)
Dec-01-22 10:23AM	The Founder of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), Joseph Payne, Just Bought A Few More Shares (Simply Wall St.)
Nov-16-22 05:24AM	These Analysts Just Made A Significant Downgrade To Their Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) EPS Forecasts (Simply Wall St.)
Nov-12-22 07:04AM	Arcturus Therapeutics Holdings Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.)
Nov-09-22 05:25PM	Arcturus Therapeutics (ARCT) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -7.58%
04:01PM	Arcturus Therapeutics Announces Third Quarter 2022 Financial Update and Pipeline Progress (Business Wire)
Nov-07-22 05:00PM	Arcturus Therapeutics to Present at the Following Investor Conferences in November (Business Wire)
Nov-04-22 05:46AM	Arcturus Therapeutics (ARCT) Surges 18.7%: Is This an Indication of Further Gains? (Zacks) +6.22%
Nov-02-22 12:00PM	Why Arcturus Therapeutics Stock Is Skyrocketing Today (Motley Fool) +18.65%
07:43AM	Arcturus Shares Jump After Collaboration With CSL For mRNA-Based Vaccines (Benzinga)
Nov-01-22 06:05PM	Arcturus Announces Collaboration with CSL to Develop and Commercialize Self-amplifying mRNA Vaccines (Business Wire)
06:00PM	CSL Enters Licensing Agreement with Arcturus Therapeutics for Next Generation mRNA Vaccine Technology (PR Newswire)
08:55AM	Harmony Biosciences Holdings, Inc. (HRMY) Beats Q3 Earnings and Revenue Estimates (Zacks)
Oct-26-22 04:30PM	Arcturus Therapeutics to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 9, 2022 (Business Wire)
Oct-18-22 08:05AM	When Will Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Become Profitable? (Simply Wall St.)
Sep-27-22 06:00PM	Arcturus Therapeutics to Attend the Following Investor Conferences (Business Wire) +8.51%
Sep-22-22 12:28PM	7 Small-Cap Stocks to Buy on the Dip or Youll Be Kicking Yourself Later (InvestorPlace)
Sep-07-22 06:44AM	Rock star Growth Puts Arcturus Therapeutics Holdings (NASDAQ:ARCT) In A Position To Use Debt (Simply Wall St.) +7.27%

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chivukula Pad	Chief Scientific Officer & COO	Mar 25 '24	Sale	35.02	17,435	610,574	473,448	Mar 27 04:15 PM
Chivukula Pad	Chief Scientific Officer & COO	Mar 19 '24	Sale	35.01	8,565	299,839	490,883	Mar 21 05:27 PM
Chivukula Pad	Chief Scientific Officer & COO	Nov 01 '23	Sale	18.72	5,000	93,602	499,448	Nov 03 04:30 PM
Chivukula Pad	Chief Scientific Officer & COO	Oct 02 '23	Sale	25.61	5,000	128,062	504,448	Oct 04 04:06 PM
Chivukula Pad	Chief Scientific Officer & COO	Sep 01 '23	Sale	31.45	5,000	157,264	509,448	Sep 05 04:05 PM
Chivukula Pad	Chief Scientific Officer & COO	Aug 01 '23	Sale	34.91	5,000	174,550	514,448	Aug 03 04:15 PM
Kummerfeld Keith C	See Remarks	Jul 14 '23	Option Exercise	8.96	6,968	62,408	7,918	Jul 18 06:50 PM
Chivukula Pad	Chief Scientific Officer & COO	Jul 14 '23	Sale	35.01	25,000	875,250	519,448	Jul 18 06:50 PM
Kummerfeld Keith C	See Remarks	Jul 14 '23	Sale	35.00	6,968	243,880	950	Jul 18 06:50 PM
Chivukula Pad	Chief Scientific Officer & COO	Jul 03 '23	Sale	28.75	5,000	143,750	544,448	Jul 07 06:01 AM
Chivukula Pad	Chief Scientific Officer & COO	Jun 01 '23	Sale	27.16	5,000	135,800	549,448	Jun 05 04:07 PM
Chivukula Pad	Chief Scientific Officer & COO	May 11 '23	Sale	30.24	7,925	239,652	554,448	May 12 04:05 PM
Chivukula Pad	Chief Scientific Officer & COO	May 10 '23	Sale	30.00	17,075	512,250	562,373	May 12 04:05 PM
Chivukula Pad	Chief Scientific Officer & COO	May 01 '23	Sale	25.93	5,000	129,650	579,448	May 03 04:08 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

ICAD

Icad Inc

ARCT

Arcturus Therapeutics Holdings Inc

Upgrade your FINVIZ experience